Email Address
info@myglpstore.com
Phone Number
+1 (904) 942-2327
Our Location
8102 Blanding blvd. Jacksonville, FL 32244
info@myglpstore.com
+1 (904) 942-2327
8102 Blanding blvd. Jacksonville, FL 32244
Price range: $119.00 through $1,142.40
CagriSema (Cagrilintide + Semaglutide) – Investigational Weight Loss Therapy
Note: This combination is still investigational in most regions. The dosing below comes from clinical trial protocols and is not approved prescribing guidance. Always consult a healthcare provider.
Key Findings from Trials
Phase 3 trials (e.g., REDEFINE 1) showed ~20.4% average weight loss at ~68 weeks.
Trials used weekly dose levels such as: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg of each drug.
Typical Clinical Trial Titration Schedule
| Week(s) | Cagrilintide (mg weekly) | Semaglutide (mg weekly) |
|---|---|---|
| 1–4 | 0.25 | 0.25 |
| 5–8 | 0.5 | 0.5 |
| 9–12 | 1.0 | 1.0 |
| 13–16 | 1.7 | 1.7 |
| 17+ | 2.4 | 2.4 |
Important Notes & Warnings
The exact approved dose for commercial use is not finalized.
Dose escalation should be done under medical supervision due to side effects such as nausea, vomiting, or gastrointestinal issues.
Injections are subcutaneous and weekly.
This is trial protocol information, not clinical prescribing advice.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
CagriSema 10mg Weight Loss + Fat Reduction Peptide is an advanced peptide formulation designed to support effective weight management and fat metabolism. Acting as a dual GLP-1 and glucagon receptor agonist, Cagrisema helps regulate appetite, improve energy utilization, and support balanced metabolic function — making it an excellent option for individuals focused on metabolic health and body composition.
At MYGLP Store, we provide authentic Cagrisema 10mg Peptides from verified suppliers to ensure consistent quality and purity. Each vial contains a precisely measured 10mg concentration, delivering accuracy and reliability for controlled use with professional-grade standards.
Supports gradual and sustainable weight management
Helps reduce stored body fat
Assists in appetite control and reduced overeating
Supports improved metabolic efficiency
Promotes long-term metabolic balance
Premium, lab-tested Cagrisema 10mg from trusted facilities
Fast and secure shipping with discreet packaging
Responsive and professional customer support
Safe online ordering with satisfaction assurance
Cagrisema mimics the activity of GLP-1 and glucagon hormones, helping the body manage hunger signals while supporting fat utilization and energy expenditure. With consistent use, it may support visible improvements in body composition when combined with balanced nutrition and regular physical activity.
Cagrisema 10mg should be used under professional supervision for therapeutic purposes. Always consult a qualified healthcare provider before starting any peptide-based program.
Support your wellness goals with Cagrisema 10mg Weight Loss + Fat Reduction Peptide.
Order online from MYGLP Store today for quality, reliability, and fast delivery.
CagriSema (Cagrilintide + Semaglutide) – Investigational Weight Loss Therapy
Note: This combination is still investigational in most regions. The dosing below comes from clinical trial protocols and is not approved prescribing guidance. Always consult a healthcare provider.
Key Findings from Trials
Phase 3 trials (e.g., REDEFINE 1) showed ~20.4% average weight loss at ~68 weeks.
Trials used weekly dose levels such as: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg of each drug.
Typical Clinical Trial Titration Schedule
| Week(s) | Cagrilintide (mg weekly) | Semaglutide (mg weekly) |
|---|---|---|
| 1–4 | 0.25 | 0.25 |
| 5–8 | 0.5 | 0.5 |
| 9–12 | 1.0 | 1.0 |
| 13–16 | 1.7 | 1.7 |
| 17+ | 2.4 | 2.4 |
Important Notes & Warnings
The exact approved dose for commercial use is not finalized.
Dose escalation should be done under medical supervision due to side effects such as nausea, vomiting, or gastrointestinal issues.
Injections are subcutaneous and weekly.
This is trial protocol information, not clinical prescribing advice.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.